Ruoqi Wang

Title: Ruoqi Wang: Innovator in Benzoazepine Compounds

Introduction

Ruoqi Wang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzoazepine compounds. His research focuses on the development of novel compounds that have potential therapeutic applications.

Latest Patents

Ruoqi Wang holds 1 patent for a benzoazepine compound, which includes a pharmaceutically acceptable salt thereof. This patent describes a pharmaceutical composition that comprises the compound and its use in the prevention or treatment of diseases related to the arginine vasopressin V1a receptor, V1b receptor, V2 receptor, sympathetic nervous system, or renin-angiotensin-aldosterone system. The compound is represented by a specific formula, with defined substituents that enhance its efficacy.

Career Highlights

Throughout his career, Ruoqi Wang has worked at esteemed institutions such as Xuzhou Medical University and ShanghaiTech University. His research has contributed to advancements in understanding and treating diseases associated with the arginine vasopressin system.

Collaborations

Ruoqi Wang has collaborated with notable colleagues, including Dong Guo and Xudong Cao. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Ruoqi Wang's work in the field of benzoazepine compounds exemplifies the impact of innovative research on pharmaceutical development. His contributions are paving the way for new treatments that address critical health issues.